Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,407,958 | 1,073,478 | 1,081,539 | 1,598,659 | 1,889,433 |
| Marketable Securities | N/A | N/A | 161,688 | N/A | N/A |
| Receivables | 3,526,449 | 3,894,150 | 3,619,040 | 3,390,088 | 3,581,385 |
| Inventories | 2,052,942 | 1,989,405 | 1,895,310 | 1,897,017 | 1,840,855 |
| Other current assets | 827,332 | 832,376 | 462,186 | 938,304 | 869,848 |
| TOTAL | $7,814,681 | $7,789,409 | $7,275,310 | $7,824,068 | $8,181,521 |
| Non-Current Assets | |||||
| PPE Net | 8,320,060 | 8,415,643 | 8,186,752 | 8,343,758 | 8,622,278 |
| Investments And Advances | 708,560 | 726,595 | 761,113 | 706,994 | 686,025 |
| Intangibles | 14,890,538 | 15,040,409 | 14,339,737 | 15,008,678 | 15,507,513 |
| Other Non-Current Assets | 1,253,368 | 1,186,483 | 1,126,124 | 1,165,637 | 1,192,516 |
| TOTAL | $25,172,526 | $25,369,130 | $24,413,726 | $25,225,067 | $26,008,332 |
| Total Assets | $32,987,207 | $33,158,539 | $31,689,036 | $33,049,135 | $34,189,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,019,435 | 1,926,100 | 1,087,629 | 1,438,941 | 2,391,289 |
| Accounts payable and accrued liabilities | 786,848 | 740,868 | 827,394 | 860,892 | 813,430 |
| Accrued Expenses | N/A | N/A | 253,367 | N/A | N/A |
| Other current liabilities | N/A | N/A | 1,467,887 | N/A | N/A |
| TOTAL | $7,424,628 | $7,242,973 | $6,159,644 | $7,043,154 | $8,064,013 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,499,005 | 6,315,270 | 6,800,101 | 6,979,668 | 6,273,995 |
| Deferred Revenues | N/A | N/A | 606,305 | N/A | N/A |
| Other Non-Current Liabilities | 300,141 | 368,894 | 612,734 | 405,261 | 342,444 |
| TOTAL | $12,750,144 | $12,715,910 | $13,198,082 | $13,350,219 | $12,803,218 |
| Total Liabilities | $20,174,772 | $19,958,883 | $19,357,726 | $20,393,373 | $20,867,231 |
| Shareholders' Equity | |||||
| Common Shares | 292,979 | 292,888 | 292,877 | 304,629 | 304,608 |
| Retained earnings | 10,290,640 | 10,500,006 | 10,254,913 | 10,054,892 | 10,077,917 |
| Other shareholders' equity | -1,838,632 | -1,681,856 | -2,205,340 | -1,723,231 | -1,110,614 |
| TOTAL | $11,631,952 | $11,998,075 | $11,215,080 | $11,493,111 | $12,125,597 |
| Total Liabilities And Equity | $31,806,724 | $31,956,958 | $30,572,806 | $31,886,484 | $32,992,828 |